162 related articles for article (PubMed ID: 36810933)
1. A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR-1 mediated mitochondrial dysfunction and apoptosis.
Ma L; Zhang H; Liu C; Liu M; Shangguan F; Liu Y; Yang S; Li H; An J; Song S; Cao Q; Qu G
Environ Toxicol; 2023 May; 38(5):1118-1132. PubMed ID: 36810933
[TBL] [Abstract][Full Text] [Related]
2. LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway.
Liu Y; Ma L; Shangguan F; Zhao X; Wang W; Gao Z; Zhou H; Qu G; Huang Y; An J; Xue J; Yang S; Cao Q
Aging (Albany NY); 2020 Sep; 12(16):16142-16154. PubMed ID: 32628130
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
Shrivastava A; Kuzontkoski PM; Groopman JE; Prasad A
Mol Cancer Ther; 2011 Jul; 10(7):1161-72. PubMed ID: 21566064
[TBL] [Abstract][Full Text] [Related]
4. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of α-mangostin in OVACAR-3 human ovarian carcinoma cells are mediated via involvement of reactive oxygen species, mitochondrial -mediated apoptosis, suppression of cell migration and invasion and m-TOR/PI3K/AKT signaling pathway.
Yu Y; Fei Z; Qin L
J BUON; 2020; 25(5):2293-2300. PubMed ID: 33277848
[TBL] [Abstract][Full Text] [Related]
7. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways].
Fan C; Zhang Y; Yang R; Wu X; Zhou J; Xue J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
[TBL] [Abstract][Full Text] [Related]
10. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
[TBL] [Abstract][Full Text] [Related]
11. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol alleviates hemorrhagic shock-induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway.
Lin B; Gao Y; Li Z; Zhang Z; Lin X; Gao J
Fundam Clin Pharmacol; 2020 Dec; 34(6):640-649. PubMed ID: 32215966
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of cucurbitacin-A in ovarian cancer cell line SKOV3 involves cell cycle arrest, apoptosis and inhibition of mTOR/PI3K/Akt signaling pathway.
Liu J; Liu X; Ma W; Kou W; Li C; Zhao J
J BUON; 2018; 23(1):124-128. PubMed ID: 29552771
[TBL] [Abstract][Full Text] [Related]
14. Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway.
Yang Q; Fei Z; Huang C
Cell Mol Biol (Noisy-le-grand); 2021 Sep; 67(2):14-19. PubMed ID: 34817343
[TBL] [Abstract][Full Text] [Related]
15. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.
Zhang L; Huo X; Liao Y; Yang F; Gao L; Cao L
Sci Rep; 2017 May; 7(1):1669. PubMed ID: 28490807
[TBL] [Abstract][Full Text] [Related]
16. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
Yang H; Li H; Lu S; Shan S; Guo Y
Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
[TBL] [Abstract][Full Text] [Related]
17. ROS accumulation contributes to abamectin-induced apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway in TM3 Leydig cells.
Zhu S; Zhou J; Sun X; Zhou Z; Zhu Q
J Biochem Mol Toxicol; 2020 Aug; 34(8):e22505. PubMed ID: 32275808
[TBL] [Abstract][Full Text] [Related]
18. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
19. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
20. α-Cyperone inhibits the proliferation of human cervical cancer HeLa cells via ROS-mediated PI3K/Akt/mTOR signaling pathway.
Pei XD; Yao HL; Shen LQ; Yang Y; Lu L; Xiao JS; Wang XY; He ZL; Jiang LH
Eur J Pharmacol; 2020 Sep; 883():173355. PubMed ID: 32687921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
